Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?
The most common lymphodepletion regimen used prior to infusion of chimeric antigen receptor-T cells (CAR-T) is cyclophosphamide (CY) in combination with fludarabine (Flu) (CY-FLU). While cyclophosphamide (CY) possesses lymphotoxic effects, it concurrently preserves regulatory T cell activity, potent...
Hlavní autoři: | , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Frontiers Media S.A.
2023-11-01
|
Edice: | Frontiers in Immunology |
Témata: | |
On-line přístup: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1329850/full |